Pharmacological treatment of the ion transport defect in cystic fibrosis.
about
Defining an inhibitory domain in the gamma subunit of the epithelial sodium channelPharmacotherapy of the ion transport defect in cystic fibrosis.Towards the pharmacogenomics of cystic fibrosis.Rescuing protein conformation: prospects for pharmacological therapy in cystic fibrosisPharmacological approaches to correcting the ion transport defect in cystic fibrosis.Evaluation of the cell viability of human Wharton's jelly stem cells for use in cell therapy.CFTR is required for cellular entry and internalization of Chlamydia trachomatis.An update on migraine: current understanding and future directions.Cellular mechanism for potentiation of Ca2+-mediated Cl- secretion by the flavonoid baicalein in intestinal epithelia.Reevaluation of Antioxidative Strategies for Birth Defect Prevention in Diabetic Pregnancies.Genistein stimulates electrogenic Cl- secretion via phosphodiesterase modulation in the mouse jejunum.Genistein stimulates electrogenic Cl(-) secretion in mouse jejunum.Methoxsalen stimulates electrogenic Cl- secretion in the mouse jejunum.Neurotransmitters, neurosteroids and neurotrophins: new models of the pathophysiology and treatment of depression.Estrogen and estrogen receptors in the modulation of gastrointestinal epithelial secretion.Mutations in potassium channel kcnd3 cause spinocerebellar ataxia type 19.Bench to bedside advances in the 21st century for primary headache disorders: migraine treatments for migraine patients.
P2860
Q34211644-3968DC5D-DBD7-4B29-B9EA-46909ABBE2DFQ34434649-56D12C6E-885E-4D0E-940C-75C5CF031266Q34609152-0F9C4D09-CDC1-4722-80F4-4BDBD14C3B90Q34817235-379BDB8D-62DB-4301-BEB0-D8E98E36D297Q35627639-AEB89493-DC0A-4709-8C0F-6D48D1729A9DQ35979655-BB92446C-AD9B-4F79-A10D-E57A58A900B6Q37853584-92F32294-CCCD-4BDA-A8D2-45FAAFAD4EBCQ38742593-3898004F-AEF2-42AB-8B61-A20C83B5ABD9Q40539038-C146B4A1-57ED-432B-AE4B-3AA73BAC90FBQ41441147-0310FCAC-6FB6-4294-90D9-54361492FF7BQ42455577-F8FBFF9F-603A-4ACB-A5B9-1EB79D7D2D86Q42466087-FB7E023C-8698-43EE-9430-2256F3E9C602Q42686204-A97382BE-4E7D-4630-A155-D95A36334EB6Q44519524-C1E8C47B-B4E1-41DF-AA13-0D3C763D4BADQ46067227-461E5913-59DA-4C0D-AECE-5140B22635B6Q48229743-59E39A3B-A568-43C2-B9E0-6E43F70FAF25Q48495487-516818E2-3A90-4A93-805A-8B19EBE7958A
P2860
Pharmacological treatment of the ion transport defect in cystic fibrosis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacological treatment of the ion transport defect in cystic fibrosis.
@ast
Pharmacological treatment of the ion transport defect in cystic fibrosis.
@en
Pharmacological treatment of the ion transport defect in cystic fibrosis.
@nl
type
label
Pharmacological treatment of the ion transport defect in cystic fibrosis.
@ast
Pharmacological treatment of the ion transport defect in cystic fibrosis.
@en
Pharmacological treatment of the ion transport defect in cystic fibrosis.
@nl
prefLabel
Pharmacological treatment of the ion transport defect in cystic fibrosis.
@ast
Pharmacological treatment of the ion transport defect in cystic fibrosis.
@en
Pharmacological treatment of the ion transport defect in cystic fibrosis.
@nl
P2860
P356
P1476
Pharmacological treatment of the ion transport defect in cystic fibrosis.
@en
P2093
Roomans GM
P2860
P356
10.1517/13543784.10.1.1
P407
P577
2001-01-01T00:00:00Z